Skip to Main Content

Paper Details

Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.
Mol Cancer Res
16
2019
Author NameAffiliation
James C CostelloUniversity of Colorado Anschutz Medical Campus
  • 1 - 1

Datasets

Release 1.2